One of the effects of the release of IL-6 in the tumor is the activation of the STAT3 signaling pathway in malignant cells, altering cell-to-cell adhesions and promoting a number of cellular processes such as increased cell proliferation, enhanced motility and the activation of the EMT program [77]. This evidence concerns the gene STAT3 and neoplasm.